Modification of plant lignin content
View Patent ↗DNA constructs comprising a first DNA segment that corresponds to at least a portion of a gene in the monolignol biosynthetic pathway, a spacer DNA segment, and a second DNA segment that is complementary to the first DNA segment can be used to reduce or modulate the lignin content in plants. In some embodiments, DNA constructs comprise at least a portion of a gene for 4CL, C3H, CCR, C4H or CCoAOMT. Vascular-preferred and constitutive promoters can be used to drive expression of the constructs.
1. A DNA construct comprising a promoter operably linked to a first DNA segment that corresponds to at least a portion of a gene in the monolignol biosynthetic pathway,
a spacer DNA segment, and
a second DNA segment that is fully complementary to the first DNA segment,
wherein the first and second DNA segments are arranged in a 5′ to 3′ direction, respectively, in the DNA construct and said gene in the monolignol biosynthetic pathway is a 4CL (4-coumarate co-enzyme A ligase) gene and
wherein said DNA construct is pARB1202 with ATCC Patent Deposit Designation Number: PTA-8633.
2. An Eucalyptus tree cell comprising the DNA construct pARB1202 with ATCC Patent Deposit Designation Number: PTA-8633, wherein the Eucalyptus tree cell expresses a double-stranded RNA encoded by the DNA construct.
3. An Eucalyptus tree comprising the Eucalyptus tree cell of claim 2 , wherein expression of the double-stranded RNA in the Eucalyptus tree results in the down regulation of a 4CL (4-coumarate co-enzyme A ligase) gene expression involved in the monolignol biosynthetic pathway in the Eucalyptus tree.
4. A method of inhibiting the expression of a 4CL (4-coumarate co-enzyme A ligase) gene involved in the monolignol biosynthetic pathway in an Eucalyptus tree, comprising transforming an Eucalyptus tree cell with the DNA construct pARB1202 with ATCC Patent Deposit Designation Number: PTA-8633, wherein the transformed Eucalyptus tree cell expresses a double-stranded RNA encoded by the DNA construct, and culturing the transformed Eucalyptus tree cell under conditions that promote regeneration of the transgenic Eucalyptus tree, wherein expression of the double-stranded RNA in the Eucalyptus tree results in the inhibition of the 4CL gene expression the Eucalyptus tree.